key: cord-0568032-5gebhq8i
authors: Rao, Priyashi; Shukla, Arpit; Parmar, Paritosh; Goswami, Dweipayan
title: Proposing a fungal metabolite-Flaviolin as a potential inhibitor of 3CLpro of novel coronavirus SARS-CoV2 using docking and molecular dynamics
date: 2020-04-08
journal: nan
DOI: nan
sha: 49297730b3146ea885ca30f4fcf37b5ea9a7fffd
doc_id: 568032
cord_uid: 5gebhq8i

Here after performing docking and molecular dynamics of various small molecules derived as a secondary metabolite from fungi, we propose Flaviolin to act as potent inhibitor of 3-chymotrypsin (3C) like protease (3CLpro) of noval corona virus SARS-CoV2 responsible for pandemic condition caused by coronavirus disease 2019 (COVID-19).

was found to be the most ideal compound to bind with 3CLpro, which was corroborated with molecular dynamics study of the flabiolin-3CL pro complex for 1000 ps. The stability of the complex could possibly pave a path for identifying/realizing the anti-3CL pro mode of action of Flaviolin. The protein 3CL pro was retrieved from Protein databank (PDB), ID 7LU6. The protein was co-crystallized with its cognate ligand, N3 (PubChem CID: 6323191). The co-ordinates of N3 binding site on 3CL pro were determined using UCSF Chimera (version 1.14). The protein structure was prepared for docking by addition of H-bonds and removal of all the co-crystallized residues (Figure 1 ). The energy minimization step was performed out using DockPrep tool (Krivov, Shapovalov, & Dunbrack, 2009 ). AM1-BCC method, known for its promptness in assigning charges to the molecules, was employed using ANTECHAMBER algorithm. while assigning the charges (J. Wang, Wang, Kollman, & Case, 2001) . Energy minimization was performed using 500 steepest descent steps with 0.02 A° step size with an update interval of 10. All the steps mentioned were performed in Chimera.

The fungal secondary metabolites, ligands, were retrieved from PubChem for the in-silico interaction assays. Prior to the molecular docking of ligand and receptor, all ligands were optimized by addition of hydrogen and energy minimization using Gasteiger algorithm (Gasteiger & Jochum, 1979) in structure editing wizard of Chimera, which works on the chemoinformatic principle of electronegativity equilibration and the files were saved in mol2 format. Receptor-ligand docking analysis was performed using AutoDock Vina (Trott & Olson, 2010) and the program was executed as an add-on in Chimera. The ligand binding site in 3CL pro was selected based on the crystallized cognate ligand (N3), attached in the original pdb file and the co-ordinates were recorded for docking of fungal ligands. Further, the coordinates of hydrophobic cavity of 3CL pro active site was used in the docking of N3 (as control) and the fungal metabolites.

In the AutoDock Vina algorithm, the following parameters were set as: (i) number of binding modes-10; (ii) exhaustiveness of search-8 and (iii) maximum energy difference-3 kcal/mol. Out of all the possible poses suggested by AutoDock Vina, the pose showing maximum hydrogen bonds and minimum binding free energy change (kcal/mol), as represented in the ViewDock window, were chosen. They were further analysed in Biovia Discovery Studio (DS) visualizer for the formation of hydrogen bonds, in addition to other supporting hydrophobic interactions, by the functional groups of ligands with the amino acids of 3CL pro . The metabolite (ligand) making maximum number of Hbonds, showing capability to form covalent interaction with 3CL pro and showed highest binding affinity was chosen for further study using molecular dynamics simulation. The structure analysis of SARS-CoV2 3CL pro shows that, the substrate binding site is located in the Cys-His catalytic dyad. Domain I extend from residues 8 to 101 and Domain II ranges from residues 102 to 184 comprise of antiparallel β-barrel structure. Domain residues is formed from residue 201 to 303 and possess five α-helices arranged into a largely antiparallel globular cluster, which is connected to domain II means of a long loop region extending from residue 185 to 200. For COVID-19, the substrate binding site is located in the cleft between Domain I and II. Binding of N3 with 3CL pro shows that it binds in the substrate binding pocket in (Figure 1 ). N3 is relatively a large molecule where its backbone forms an antiparallel sheet with residues 164 to168 (His164, Glu166, Met165, Leu167, Pro168) of 3CL pro while also interacting with residues 189 to191 (Gln189, Thr190, Ala191) of the loop that links Domain II and III. The group of scientists who co-crystalized this protein with N3 also suggest strong covalent bond formed by Cys145 of 3CL pro with N3 of the 1.8 Å length, in turn, making the interaction with of this inhibitor bind irreversibly with the protein. Briefly, the inhibitor N3 makes six hydrogen bonds (with Gly143, Phe140, His163, His164, Glu166 and Thr190), one amide pi-stacked interaction (with Leu141), five pi-alkyl interactions (with His41, Met49, Leu167, Pro168 and Ala191) two carbon hydrogen bonds (Met165 and His172) and one van der Walls interactions (with Asn142) with 3CL pro .

For the docking of fungal metabolites with 3CLpro, the coordinates of N3 binding were used to assess the binding affinity of various fungal metabolites with 3CL pro . On performing the docking of all the metabolites one by one with 3CL pro , it was observed that, only five molecules were able to make three hydrogen bonds or more with 3CL pro at the binding cleft of N3. These were Asperic acid, Aspernigrin A, Aurosperone B, Carbomymethyl-3-hexylmaleic acid and the best one, flaviolin. Flaviolin showed to make eight hydrogen bonds in total (with Leu141, Gly143, Ser144, Cys145, His163, Glu166 and Gln189) and made one carbon hydrogen bond (with Asn142) and the docking energy as predicted by AutoDock Vina was -7.3 kcal/mol for the best pose ( Figure 2 ). As shown previously, N3 showed interaction with residues 164 to168 (His164, Glu166, Met165, Leu167, Pro168) of 3CL pro along with interacting with residues 189 to191 (Gln189, Thr190, Ala191) of the loop that links Domain II and III, flaviolin also showed similar interaction with 3CL pro . All these properties make flaviolin as the best choice as the most suitable inhibitor for 3CL pro . When the docked best pose of flaviolin was made to superimpose with that of N3 on 3CLpro, it was observed that it was able to bind exactly at the same N3 binding cleft (Figure 1) . Moreover, the docking analysis suggested that flaviolin interacted with almost all similar amino acids akin to N3-3CL pro binding.

Further, to validate the results of docking, the comparative molecular dynamics (MD) simulation was performed in two pairs of experiments studying (i) N3-3CL pro and (ii) Flaviolin-3CL pro individually and their results were compared. Steepest descent energy minimization was performed for both the systems, and the systems were equilibrated under NVT (constant number of particles, volume and temperature) conditions for 1000 ps at 300 K, and the MD run was initiated. Once the NVT run was completed the system was proceeded with NPT (constant number of particles, pressure, and temperature) simulation and MD run was performed for 1000 ps. Trajectories were analysed for rootmean-square deviation (RMSD), root-mean-square fluctuation (RMSF), radius of gyration (Rg) and the number of H-bonds formed between the ligand and proteins using 'gmx rms','gmx rmsf', 'gmx gyrate' and 'gmx hbond' of GROMACS utilities (Bekker et al., 1993; Pronk et al., 2013) . Ligandprotein stability was determined by the dynamics of hydrogen bonds between ligand and protein with respect to time. XMgrace tool was used to prepare the graphs (Turner, Land-Margin Research, & Technology, 2005) . and Flaviolin is shown in Figure 5e and f respectively. As both the ligands are differing in size and shapes, comparing their RMSF doesn't hold any importance.

The intermolecular hydrogen bonding between the protein and the ligand plays an essential role in stabilizing the protein-ligand complexes. The stability of the hydrogen bond network formed between (i) N3-3CL pro and (ii) Flaviolin-3CL pro were calculated throughout the simulation at 300 K for the ligated system and the results are depicted in Figure 5e and f. The N3-3CL pro complex exhibited four hydrogen H-bonds upto 500ps and thereafter the number of hydrogen bond increased to the average of six suggesting the ligand getting more stable during the course of MD run. While for Flaviolin-3CLpro, there were consistently six hydrogen bonds being formed throughout the simulation. Overall scenario suggests both ligands fits in to the binding cleft making appropriate hydrogen bonds.

From the MD analysis it can be said that the protein behaves identical in presence of both the ligands, N3 and Flaviolin both forms similar hydrogen bonds with 3CL pro and hence the efficacy of Flaviolin to interact with 3CL pro can be depicted to be at par with N3. The pkCSM -pharmacokinetics server (Pires, Blundell, & Ascher, 2015) was used to predict the ADMET (absorption-distribution-metabolism-excretion-toxicity) properties of N3 and flaviolin. It predicted both physiochemical and pharmacological properties. SMILES (Simplified Molecule Input Line Entry Specification) of the compounds were retrieved from

PubChem and uploaded to pkCSM -pharmacokinetics server (Table 1) . Of all the tests, Flaviolin showed better distribution based on the values of volume of Distribution (VDss).

Flaviolin also showed fraction unbounded showing its ability to distribute in tissues of body more effectively. Flaviolin does not even interfere the Cytochrome (CYP) and has better renal clearance. Lastly the toxicity by Flaviolin on liver cells is also not predicted and hence it has better drug like properties when compared to N3. With efforts been made to control the pandemics of SAR-CoV2 in the form of novel coronavirus, to find the lead compound against the target protein that can suppress its.

Reflecting back in the history, fungal metabolites have been a boon for the mankind, starting from antibiotics to flavoring agents to food preservatives. Fungi are known to produce large amounts of secondary metabolites and by chance that might interact with 3CL pro , with this rationale the fungal metabolites were looked for pursuing this research. Previously, the potentials of fungal metabolites as anti-viral agents are explored and the success was promising. The anti-viral compounds from fungal origin is vividly described by Linnakoski et al. (2018) where the promising anti-viral compounds portrayed were belong to the chemical class of Indole alkaloids, Non-ribosomal peptides, Polyketides, Terpenoids. With efforts been made to control the pandemic of SAR-CoV2 in the form of novel Coronavirus, to find a lead compound against the target protein that can suppress its. We here are proposing Flaviolin to interact with one of the important target proteins of SAR-CoV2, 3CL pro and block its function as deduced using docking and molecular dynamics.

SARS and MERS: recent insights into emerging coronaviruses

An algorithm for the perception of synthetically important rings

LINCS: a linear constraint solver for molecular simulations

Structure of Mpro from COVID-19 virus and discovery of its inhibitors

Structure of Mpro from COVID-19 virus and discovery of its inhibitors

Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4-The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS)

COVID-19 Docking Server: An interactive server for docking small molecules, peptides and antibodies against potential targets of COVID-19

Improved prediction of protein side-chain conformations with SCWRL4

Antiviral agents from fungi: Diversity, mechanisms and potential applications

Inhibition of the Main Protease 3CL-pro of the Coronavirus Disease 19 via Structure-Based Ligand Design and Molecular Modeling

An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy

pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures

5: a high-throughput and highly parallel open source molecular simulation toolkit

The newly emerged SARS-like coronavirus HCoV-EMC also has an" Achilles' heel": current effective inhibitor targeting a 3C-like protease

Studies on pyranonigrins-isolation of pyranonigrin E and biosynthetic studies on pyranonigrin A

Identification of the pyranonigrin A biosynthetic gene cluster by genome mining in Penicillium thymicola IBT 5891

AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

GROMACS: fast, flexible, and free

Crystal Structure of Feline Infectious Peritonitis Virus Main Protease in Complex with Synergetic Dual Inhibitors

Structure of Main Protease from Human Coronavirus NL63: Insights for Wide Spectrum Anti-Coronavirus Drug Design. Sci Rep

Michael Acceptor-Based Peptidomimetic Inhibitor of Main Protease from Porcine Epidemic Diarrhea Virus

Antechamber: an accessory software package for molecular mechanical calculations

A new coronavirus associated with human respiratory disease in China

Production of authentic SARS-CoV Mpro with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction

Drug design targeting the main protease, the Achilles' heel of coronaviruses

Design of wide-spectrum inhibitors targeting coronavirus main proteases

Authors are thankful to Gujarat University for providing necessary facilities to perform experiments.

This article does not contain any studies with human participants or animals performed by any of the authors.

The authors declare that they have no conflict of interest.